1H2017 ended with 37% growth in portfolio. Sadly no improvement. Seems like this portfolio is stagnating.
Aemulus. Top performer. Declared Syariah compliant stock, which it should be since the beginning. Expecting further growth in 2H2017.
Ghlsys. Still tanking. Now with all of the good news ended, investors are waiting for a favorable result.
Hsplant. CPO price is the key.
Muhibah. Pending for billing for its existing contracts. Possibility of new contracts from Rapid, LRT3.
Yeelee. Suffered poor result last quarter. Still seeing growth due to the nature of its products.